230 related articles for article (PubMed ID: 17507072)
1. Comparative analysis of the alphavirus-based vectors expressing Rift Valley fever virus glycoproteins.
Gorchakov R; Volkova E; Yun N; Petrakova O; Linde NS; Paessler S; Frolova E; Frolov I
Virology; 2007 Sep; 366(1):212-25. PubMed ID: 17507072
[TBL] [Abstract][Full Text] [Related]
2. Vaccination with DNA plasmids expressing Gn coupled to C3d or alphavirus replicons expressing gn protects mice against Rift Valley fever virus.
Bhardwaj N; Heise MT; Ross TM
PLoS Negl Trop Dis; 2010 Jun; 4(6):e725. PubMed ID: 20582312
[TBL] [Abstract][Full Text] [Related]
3. Development and characterization of a Rift Valley fever virus cell-cell fusion assay using alphavirus replicon vectors.
Filone CM; Heise M; Doms RW; Bertolotti-Ciarlet A
Virology; 2006 Dec 5-20; 356(1-2):155-64. PubMed ID: 16945399
[TBL] [Abstract][Full Text] [Related]
4. [Study on DNA immune of envelope protein gene of Rift Valley Fever Virus].
Wang QH; Wang XJ; Hu S; Ge JY; Bu ZG
Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):677-81. PubMed ID: 17944371
[TBL] [Abstract][Full Text] [Related]
5. The Old World and New World alphaviruses use different virus-specific proteins for induction of transcriptional shutoff.
Garmashova N; Gorchakov R; Volkova E; Paessler S; Frolova E; Frolov I
J Virol; 2007 Mar; 81(5):2472-84. PubMed ID: 17108023
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of protein expression by alphavirus replicons by designing self-replicating subgenomic RNAs.
Kim DY; Atasheva S; McAuley AJ; Plante JA; Frolova EI; Beasley DW; Frolov I
Proc Natl Acad Sci U S A; 2014 Jul; 111(29):10708-13. PubMed ID: 25002490
[TBL] [Abstract][Full Text] [Related]
7. An alphavirus replicon-derived candidate vaccine against Rift Valley fever virus.
Heise MT; Whitmore A; Thompson J; Parsons M; Grobbelaar AA; Kemp A; Paweska JT; Madric K; White LJ; Swanepoel R; Burt FJ
Epidemiol Infect; 2009 Sep; 137(9):1309-18. PubMed ID: 19171081
[TBL] [Abstract][Full Text] [Related]
8. Baculovirus expression of the M genome segment of Rift Valley fever virus and examination of antigenic and immunogenic properties of the expressed proteins.
Schmaljohn CS; Parker MD; Ennis WH; Dalrymple JM; Collett MS; Suzich JA; Schmaljohn AL
Virology; 1989 May; 170(1):184-92. PubMed ID: 2655274
[TBL] [Abstract][Full Text] [Related]
9. Microencapsulated plasmids expressing Gn and Gc glycoproteins of Rift Valley Fever virus enhance humoral immune response in mice.
Selina O; Imatdinov I; Balysheva V; Akasov R; Kryukov A; Balyshev V; Markvicheva E
Biotechnol Lett; 2020 Apr; 42(4):529-536. PubMed ID: 31983039
[TBL] [Abstract][Full Text] [Related]
10. Stable, high-level expression of reporter proteins from improved alphavirus expression vectors to track replication and dissemination during encephalitic and arthritogenic disease.
Sun C; Gardner CL; Watson AM; Ryman KD; Klimstra WB
J Virol; 2014 Feb; 88(4):2035-46. PubMed ID: 24307590
[TBL] [Abstract][Full Text] [Related]
11. Non-viral amplification systems for gene transfer: vectors based on alphaviruses.
Smerdou C; Liljeström P
Curr Opin Mol Ther; 1999 Apr; 1(2):244-51. PubMed ID: 11715947
[TBL] [Abstract][Full Text] [Related]
12. Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses.
Pushko P; Geisbert J; Parker M; Jahrling P; Smith J
J Virol; 2001 Dec; 75(23):11677-85. PubMed ID: 11689649
[TBL] [Abstract][Full Text] [Related]
13. Stable alphavirus packaging cell lines for Sindbis virus and Semliki Forest virus-derived vectors.
Polo JM; Belli BA; Driver DA; Frolov I; Sherrill S; Hariharan MJ; Townsend K; Perri S; Mento SJ; Jolly DJ; Chang SM; Schlesinger S; Dubensky TW
Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4598-603. PubMed ID: 10200308
[TBL] [Abstract][Full Text] [Related]
14. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
[TBL] [Abstract][Full Text] [Related]
15. Rift Valley fever virus noncoding regions of L, M and S segments regulate RNA synthesis.
Gauliard N; Billecocq A; Flick R; Bouloy M
Virology; 2006 Jul; 351(1):170-9. PubMed ID: 16630639
[TBL] [Abstract][Full Text] [Related]
16. Alphavirus-Based Vaccines.
Lundstrom K
Methods Mol Biol; 2017; 1581():225-242. PubMed ID: 28374252
[TBL] [Abstract][Full Text] [Related]
17. Alphavirus-Based Vaccines.
Lundstrom K
Methods Mol Biol; 2016; 1404():313-328. PubMed ID: 27076308
[TBL] [Abstract][Full Text] [Related]
18. Alphavirus-Based Antigen Preparation.
Lundstrom K
Methods Mol Biol; 2021; 2183():63-81. PubMed ID: 32959241
[TBL] [Abstract][Full Text] [Related]
19. Rift Valley fever virus Gn V5-epitope tagged virus enables identification of UBR4 as a Gn interacting protein that facilitates Rift Valley fever virus production.
Bracci N; de la Fuente C; Saleem S; Pinkham C; Narayanan A; García-Sastre A; Balaraman V; Richt JA; Wilson W; Kehn-Hall K
Virology; 2022 Feb; 567():65-76. PubMed ID: 35032865
[TBL] [Abstract][Full Text] [Related]
20. Alphavirus vectors for cancer gene therapy (review).
Yamanaka R
Int J Oncol; 2004 Apr; 24(4):919-23. PubMed ID: 15010830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
